I decided to sell after all.

I read 2 days ago that $NKTR (+2,35%) does not intend to submit an application for approval for the drug whose positive study data was responsible for the rapid rise this week until 2029. Until then, there will certainly be other opportunities. I therefore entered an SL order, which I kept increasing and which was then triggered yesterday.